March 2015


With spring comes allergies, and for anyone with lung disease this could mean an even more difficult time breathing. Fortunately, with the new season comes new treatments for lung disease. The Lung Institute recently announced a new treatment for sarcoidosis and a new treatment protocol that allows for the extraction of cells from bone marrow.

In this edition of our newsletter, learn more about these new treatment options and how the Lung Institute can help bring life back within reach.

Helping you to breathe easier,


Lung Institute

National COPD Awareness MonthFind Out About Lung Institute Seminars

We’ve recently added a new section to our website highlighting upcoming events and seminars. These seminars are a great way to learn how cellular therapy is used to treat lung disease, hear testimonials from our patients and get answers to your questions directly from the presenting physician.

Our stem cell seminars are held regularly at our Tampa, Nashville and Scottsdale clinics. RSVP to attend our next seminar at a location that is nearest to you.

Unable to attend a live seminar?

Sign up for a live interactive webcast.



Grilled Greek Salmon SaladOxygen-rich Diet Recipe: Grilled Greek Salmon Salad

Nothing tastes as good as healthy feels. You’ve heard it over and over again. Have you ever found yourself asking why everything that tastes good is always so bad for you? We have disproved this notion with a recipe for a grilled Greek salmon salad that can help boost the oxygen in your blood and leave your taste buds happy. Salmon, feta cheese, dried cranberries and fresh tomatoes come together in a satisfying and easy to make dinner.

Read About How You Can Make This Tasty Recipe At Home





* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.